BusinessEsperion Therapeutics Provides Bempedoic Acid Development Program Updates; Reports Third Quarter 2016 Financial ResultsBy Nasdaq OMXNov 3, 2016, 8:06 PM UTC
BusinessEsperion Therapeutics to Present at the Credit Suisse 25th Annual Healthcare ConferenceBy Nasdaq OMXNov 1, 2016, 8:30 PM UTC
BusinessBempedoic Acid Global Phase 3 Clinical Program to Include Patients on Any Statin at Any DoseBy Nasdaq OMXOct 13, 2016, 11:30 AM UTC
BusinessEsperion Therapeutics to Present at the Barclays Global Healthcare ConferenceBy Nasdaq OMXMar 8, 2016, 9:30 PM UTC
BusinessSECURITIES NOTICE: Rosen Law Firm Reminds Esperion Therapeutics, Inc. Investors of Important March 14, 2016 Deadline in Class Action – ESPRBy Nasdaq OMXMar 4, 2016, 8:30 PM UTC
BusinessEsperion Therapeutics Provides Bempedoic Acid Development Program Update; Reports Fourth Quarter and Full Year 2015 Financial ResultsBy Nasdaq OMXFeb 25, 2016, 9:05 PM UTC
BusinessEsperion Therapeutics to Present at the 2016 RBC Capital Markets Global Healthcare ConferenceBy Nasdaq OMXFeb 16, 2016, 9:30 PM UTC
BusinessEQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Esperion Therapeutics, Inc. -- ESPRBy Nasdaq OMXFeb 11, 2016, 9:40 PM UTC
